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Dendritic cells (DCs) are an important early target cell for many mosquito-borne viruses, and in many cases
mosquito-cell-derived arboviruses more efficiently infect DCs than viruses derived from mammalian cells.
However, whether mosquito-cell-derived viruses differ from mammalian-cell-derived viruses in their ability to
induce antiviral responses in the infected dendritic cell has not been evaluated. In this report, alphaviruses,
which are mosquito-borne viruses that cause diseases ranging from encephalitis to arthritis, were used to
determine whether viruses grown in mosquito cells differed from mammalian-cell-derived viruses in their
ability to induce type I interferon (IFN) responses in infected primary dendritic cells. Consistent with previous
results, mosquito-cell-derived Ross River virus (mos-RRV) and Venezuelan equine encephalitis virus (mos-
VEE) exhibited enhanced infection of primary myeloid dendritic cells (mDCs) compared to mammalian-cell-
derived virus preparations. However, unlike the mammalian-cell-derived viruses, which induced high levels of
type I IFN in the infected mDC cultures, mos-RRV and mos-VEE were poor IFN inducers. Furthermore, the
poor IFN induction by mos-RRV contributed to the enhanced infection of mDCs by mos-RRV. These results
suggest that the viruses initially delivered by the mosquito vector differ from those generated in subsequent
rounds of replication in the host, not just with respect to their ability to infect dendritic cells but also in their
ability to induce or inhibit antiviral type I IFN responses. This difference may have an important impact on the
mosquito-borne virus’s ability to successfully make the transition from the arthropod vector to the vertebrate
host.
Mosquito-borne viruses, which include a wide range of hu-
man pathogens, including flaviviruses, alphaviruses, and bun-
yaviruses, cause diseases ranging from arthritis to hemorrhagic
fever or encephalitis (10, 31, 38, 42, 43). A number of mosquito-
borne viruses are thought to initially interact with and replicate
in myeloid dendritic cells (mDCs) in the skin following delivery
from the mosquito vector (26, 36, 46), and it is likely that early
interactions with mDCs play an important role in determining
whether the virus successfully establishes infection and ulti-
mately causes disease.
One of the most important obstacles that an invading virus
has to overcome is the host type I interferon (IFN) system,
which plays an essential role in the early control of many viral
infections, modulates downstream aspects of other compo-
nents of the innate immune response, and helps orchestrate
the adaptive immune response (reviewed in reference 3). This
may be particularly important for mosquito-borne pathogens
that initially replicate in dendritic cells of myeloid origin, since
mDCs are capable of mounting robust type I interferon re-
sponses (7). Several arthropod-borne viruses, including mem-
bers of Flaviviridae and Bunyaviridae, encode antagonists of the
type I IFN system that can block multiple components in the
type I IFN pathway (33, 44). However, mDCs are different
from many other cell types, such as fibroblasts, since they can
rapidly respond to the incoming virus and do not require viral
replication to initiate a type I IFN response (15), which may
make these cells less susceptible to virally encoded interferon
antagonists than other cell types. Therefore, other factors, such
as immune-suppressive components of mosquito saliva, may
also promote transmission to the vertebrate host (23, 24, 37).
However, whether the virus derived from the mosquito differs
from virus derived from mammalian cells in its ability to induce
an antiviral response in mDCs or other cell types has not been
evaluated.
Alphaviruses are single-stranded, positive-sense RNA vi-
ruses that are transmitted by mosquitoes and cause human
diseases ranging from infectious arthritis to lethal encephalitis
(reviewed in reference 42). Alphaviruses are extremely ame-
nable to genetic manipulation and, in addition, well-estab-
lished cell culture and animal pathogenesis models exist for
several of these viruses (31, 42, 43, 45). Furthermore, sev-
eral alphaviruses target to dendritic cells in vivo (26, 36).
Additionally, mosquito-cell-derived Sindbis virus has been
shown to preferentially infect human mDCs due to interac-
tions between the dendritic-cell-specific C-type lectin DC-
SIGN and high-mannose glycans on the mosquito-cell-de-
rived virion (18). Therefore, alphaviruses represent an
extremely useful set of viruses for studying how mosquito-
borne viruses interact with mDCs.
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In this study, Ross River virus (RRV) and other alphaviruses
were grown in either mosquito or mammalian cell cultures
(mam- or mos-RRV) and evaluated for their ability to infect
murine or human mDCs and induce an antiviral type I inter-
feron response. These studies demonstrate that for several
alphaviruses, the mosquito-cell-derived virus was able to effi-
ciently infect the mDCs but was an extremely poor inducer of
type I IFN, while the same virus derived from mammalian cells
was a potent IFN inducer. These results strongly suggest that
alphaviruses delivered from mosquito vectors are able to infect
mDCs while simultaneously avoiding the type I IFN response.
MATERIALS AND METHODS
Virus stocks and cell lines. Ross River virus (T48 strain) was produced from
the pRR64 infectious clone (generously provided by Richard Kuhn, Purdue
University), which includes the full-length T48 cDNA clone (21) originally iso-
lated from Aedes vigilax mosquitoes in Queensland, Australia (8). The RR64-
GFP virus, which expresses green fluorescent protein (GFP) from a second viral
subgenomic promoter, was constructed as described previously (31). Briefly,
genome-length viral RNA was transcribed using mMessage mMachine SP6 in
vitro transcription kits (Ambion), and the RNA was electroporated into baby
hamster kidney-21 cells (BHK-21; ATCC CCL-10). Twenty-four hours postelec-
troporation, supernatants were harvested, the virus was pelleted through a 20%
(wt/vol) sucrose cushion by ultracentrifugation at 72,000  g, and the virus was
resuspended in phosphate-buffered saline (PBS). Venezuelan equine encepha-
litis virus (VEE), which had been engineered to express GFP from a second
subgenomic promoter, was generated from clone dpV3000-GFP in a similar
manner as described previously (45). To generate mos-RRV or mos-VEE, virus
was passaged a single time at a multiplicity of infection (MOI) of 0.1 in C6/36
Aedes albopictus, and input virus was washed off after a 1-hour infection. Alter-
natively, C6/36 cells were electroporated with in vitro-transcribed RR64 RNA
using the same protocol to generate BHK-cell-derived virus. Both passaged and
electroporated mos-RRV showed equivalent levels of IFN induction (data not
shown). At 18 to 24 h, supernatant was collected and concentrated. RRV gen-
erated from Chinese hamster ovary (CHO) cells was obtained by a single passage
of mam-RRV through either the parental Pro-5 (ATCC CRL-1781) or mutant
Lec-1 (ATCC CRL-1735) CHO cells. Virus stocks were titrated on BHK-21 cells
by standard plaque assay. Barmah Forest virus (BFV; strains 10E101SC and
BH2193) (22) was grown in BHK-21 cells to generate mam-BFV. To generate
mos-BFV, virus was passaged a single time in C6/36 Aedes albopictus cells for 18
to 24 h, and supernatant was collected and concentrated by ultracentrifugation
the same way as for mam-BFV. Both virus stocks were reconstituted in phos-
phate-buffered saline, and titers were determined on BHK-21 cells by standard
plaque assay.
BHK-21 cells were grown in alpha minimal essential medium (Gibco) with
10% fetal bovine serum (FBS), 10% tryptose phosphate broth, and 0.29 mg of
L-glutamine per ml. C6/36 cells were grown in minimal essential medium with
Earl’s salts and supplemented with 5% FBS, nonessential amino acids, penicillin,
and streptomycin.
Bone marrow dendritic cell cultures and virus infection conditions. Murine
bone marrow-derived dendritic cells were generated from 129 Sv/Ev mice and
129 Sv/Ev  RKO bone marrow as described previously (39). Bone marrow was
harvested from the femur and tibia of 1- to 3-month-old mice, red blood cells
were lysed, and cells were resuspended in RPMI 1640, 10% FBS, penicillin,
streptomycin, and 2-mercaptoethanol. Cells were grown in suspension in the
presence of recombinant granulocyte-macrophage colony stimulating factor and
interleukin-4 for 7 days at 20 ng/ml (days 0 to 3), 10 ng/ml (days 3 to 5), and 5
ng/ml (days 5 to 7) in ultra-low-cluster six-well Costar plates (Costar) to obtain
an immature dendritic cell phenotype, which was confirmed by staining with
antibodies to CD11b, CD11c, B220, CD80, CD86, and CD40 (eBioscience). At
day 7 post-bone marrow harvest, cells were infected with either RRV or VEE for
2 hours in a total volume of 0.2 ml. Following infection, 0.5 ml of medium was
added back to the culture. At various times postinfection, supernatants were
removed and assayed for type I IFN levels, while the cells were fixed in 4%
paraformaldehyde and analyzed by flow cytometry for GFP expression to quan-
tify the percentage of infected cells within the culture.
Generation of human monocyte-derived DCs. Peripheral blood was obtained
from healthy volunteers and diluted 1/2 in PBS. The peripheral blood mononu-
clear cells were isolated following separation over lymphocyte separation me-
dium (ICN Biomedicals), washed in PBS, and resuspended in RPMI 1640 me-
dium as described for murine DCs. Cells were plated in culture flasks and
allowed to adhere for 2 h, at which time nonadherent peripheral blood mono-
nuclear cells were removed and discarded. Cells were cultured in the presence of
800 IU/ml granulocyte-macrophage colony-stimulating factor and 500 IU/ml
interleukin-4 (Peprotech) for 6 days, with fresh cytokines added every 48 to 72 h.
On day 6, cells were resuspended, phenotyped by flow cytometry staining with
anti-CD11c, HLA-DR, DC-SIGN, and CD14 (BD Biosciences Pharmingen), and
infected in the same manner as the murine mDCs. Experiments were performed
on blood from two separate donors.
IFN bioassay. Type I interferon levels in cell culture supernatants were mea-
sured by interferon bioassay as described previously (2, 45). Briefly, L929 mouse
fibroblasts (ATCC CCL-1), human lung carcinoma A549 cells (CCL-185), or
Vero cells (CRL-1586) were seeded in 96-well plates. All samples were acidified
to a pH of 2.0 for 24 h and then were neutralized to pH 7.4 and further
inactivated by UV light for 10 min prior to titration by twofold dilutions down the
plate. Twenty-four hours after the addition of the supernatant, interferon-sen-
sitive encephalomyocarditis virus or Sindbis virus was added to each plate. At 18
to 24 h postinfection (hpi), 3-[4,5-dimethylthylthiazol-2yl]-2,5-diphenyltetrazo-
lium bromide (MTT; Sigma), an indicator of viable cells, was added to each well
in the murine bioassay only. The MTT product was then dissolved in isopropa-
nol–0.4% HCl, and absorbance was read on a microplate reader at 570 nm.
Alternatively, human bioassay plates were scored for 50% cytopathic effect as an
indicator of IFN concentration. Each plate contained an IFN standard (Chemi-
con or R&D Systems) to determine the international units (IU/ml) of type I IFN
in each culture.
Real-time PCR and semiquantitative PCR assays. Total cellular RNA was
isolated with the Ultraspec RNA isolation reagent (Biotex), and total RNA was
reverse transcribed with a cDNA archive kit (Applied Biosystems). TaqMan
real-time PCR was performed with primer probe sets for specific genes of
interest (Applied Biosystems) and analyzed on the Prism 7000 machine (Applied
Biosystems). For all samples, an equivalent amount of RNA was reverse tran-
scribed and an internal reference control of 18s rRNA or glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) was included. For studies with Barmah
Forest virus, total RNA was isolated from cells by standard methods using
RNAwiz (Ambion). Reverse transcriptase PCR (RT-PCR) was then carried out
as previously described (28). Primer sequences for hypoxanthine phosphoribo-
syltransferase and IFN- have been described previously (27). For RRV genome
analysis, primers for sequences specific to the NSP1 and NSP4 regions of RRV
were used. The primer sequences were the following: for NSP1, forward, 5-A
GAGTGCGGAAGACCCAGAG-3, and reverse, 5-CCGTGATCTTACCGG
ACACA-3; for NSP4, forward, 5-ACCCGACAGTGGCTAGTTAC-3, and re-
verse, 5 CGGTTGGTGGTAAGCATGAT-3). Purified virions were isolated
with the MagMax viral RNA extraction kit (Ambion) and reverse transcribed
using the cDNA archive kit (Applied Biosystems), and cDNA was used for
quantitative real-time PCR using Sybr Green (Applied Biosystems). A standard
curve was generated to ensure optimal primer efficiency, and relative differences
between virus stocks were calculated.
Specific infectivity assays. The specific infectivity of RRV produced in
BHK-21 cells or C6/36 was performed as previously described (19). In brief, at 4
hpi culture medium was replaced with methonine-free medium. At 8 hpi, virus
growth medium was radiolabeled with [35S]methionine at 10 Ci/ml. At 24 hpi,
virus was harvested and banded twice over two 20/60% discontinuous sucrose
gradients in PBS and pelleted over a 20% sucrose cushion at 70,000  g. Virus
was reconstituted in PBS, total counts per minute (cpm) were measured, and
equal counts per minute were used for a standard plaque assay on BHK-21 cells.
The cpm/PFU ratio was then calculated to determine particle/PFU ratios for
each virus preparation.
Western blotting. Purified RRV virions were analyzed on a 10% sodium
dodecyl sulfate-polyacrylamide gel electrophoresis gel, and Western blot assays
were performed using an anti-RRV mouse hyperimmune ascites fluid. Total
fluorescence was detected by ECL Plus immunofluorescence (Amersham), and
fluorescence was measured on a phosphorimager (Storm Scanner) and quanti-
fied with ImageQuant 5.0.
Statistics. All groups were compared using a two-tailed unpaired Student t test
or a one-way analysis of variance (ANOVA) where indicated using GraphPad
InStat software.
RESULTS
Mosquito- and mammalian-cell-derived RRV differ in their
ability to induce type I interferon in bone marrow-derived
dendritic cells. In order to assess the ability of mammalian-
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and mosquito-cell-derived virions to infect murine mDCs,
RRV expressing GFP was grown in either BHK-21 cells or
C6/36 Aedes Albopictus cells, and GFP was measured as an
indicator of infection. Consistent with previous reports with
Sindbis virus and West Nile virus infection of human dendritic
cells (6, 18), mos-RRV infected a higher percentage of mDCs
than mam-RRV (Fig. 1A and B) at 12 hpi. However, although
mos-RRV infected a higher percentage of the mDCs, mos-
RRV-infected cultures produced little type I IFN, while mam-
RRV induced a robust IFN response (Fig. 1C) as measured in
a type I IFN bioassay. Similar results were obtained when RRV
without the GFP transgene was used (data not shown). These
FIG. 1. mos-RRV infects myeloid bone marrow-derived dendritic cells more efficiently than mam-RRV but induces less type I interferon. A.
mos-RRV infected a higher percentage of mDCs than mam-RRV, as shown in representative histograms measuring GFP expression in infected
mDCs at 12 h postinfection by flow cytometry. B. Data from panel A, displaying the mean and standard error of the mean (SEM) of infection
percentages from three independent samples. C. Type I IFN responses measured from the same cultures as in panel B. Each bar represents the
mean and SEM of three independent samples. D. Myeloid DCs were infected with either mam- or mos-RRV, and RNA was isolated at 2 hpi and
analyzed by real-time RT-PCR for IFN- message. Data are presented as fold induction over mock and normalized to 18S rRNA. E. mam-RRV
induces more type I IFN than mos-RRV in human monocyte-derived dendritic cells. Immature human DCs were generated and infected with
either mam- or mos-RRV at an MOI of 20. At 18 h postinfection, type I IFN responses were measured by IFN bioassay. F. UV-inactivated
mam-RRV induces type I IFN, while UV-inactivated mos-RRV does not induce type I IFN. mam- or mos-RRV was inactivated by UV light, and
type I IFN responses were measured from infected mDCs by IFN bioassay. All data are representative of at least two to three independent
experiments. Differences between mam- and mos-RRV were statistically significant (P  0.05) for panels B to E as determined by one-way
ANOVA. mam- and mos-RRV corresponding time points in panel F were statistically different as determined by Student’s unpaired t test.
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results were confirmed by quantitative RT-PCR to measure
IFN- mRNA levels in the virally infected cultures. Consistent
with the bioassay results, mam-RRV induced an approximately
13-fold increase in IFN- message over mock-infected cul-
tures, compared to an approximately 2-fold induction by mos-
RRV (Fig. 1D). These results strongly suggest that mos-RRV,
but not mam-RRV, was able to suppress or avoid the induction
of type I IFN following infection of mDCs.
To determine if type I IFN differences between the mam-
malian- and mosquito-cell-derived viruses extended beyond
murine DCs, human monocyte-derived DCs were infected with
either mam- or mos-RRV and assessed for infectivity and IFN
production. When these cells were infected with mam-RRV or
mos-RRV, little productive infection was observed with either
virus as determined by GFP expression (data not shown).
However, when type I IFN levels in these cultures were
assessed by bioassay, significantly higher levels of type I IFN
were observed in supernatants from mam-RRV-infected
DCs compared to mos-RRV-infected cells (Fig. 1E). These
results suggest that the differences in type I IFN induction
between the mosquito- and mammalian-cell-derived viruses
also extend to human DCs, which further underscores the
potential relevance of this phenotype to alphavirus-induced
disease in humans.
Another important question was whether type I IFN induc-
tion by the mammalian-derived virus was replication depen-
dent, since UV-inactivated Semliki Forest virus (SFV) is a
potent inducer of type I IFN in mDCs. Consistent with the
SFV findings, UV-inactivated RRV was able to induce type I
IFN (Fig. 1F). However, heat inactivation of the virus ablated
type I IFN induction and IFN induction copurified with the
viral particle (data not shown). These data suggest that an
intact particle, but not productive replication, is required for
IFN induction by mam-RRV. This also suggests that endo-
toxin, which previously has been shown to be heat stable (29)
and is a potent inducer of type I IFN (17), did not contribute
to the type I IFN induction by the mammalian-cell-derived
virus. Similar to infectious mos-RRV, UV-inactivated mos-
RRV did not induce type I IFN, suggesting that the lack of
type I IFN induction by mos-RRV was not dependent on viral
replication, which indicated that a virally encoded de novo-
synthesized factor was not required for this effect.
The differences in type I IFN induction between mam- and
mos-RRV might simply reflect a difference in the kinetics of
type I IFN induction. Therefore, mDC cultures were infected
with mam-RRV or mos-RRV and both the percentage of in-
fected cells and the levels of type I IFN produced in the
cultures were evaluated at several times postinfection. As
shown in Fig. 2, mos-RRV infected a higher percentage of
mDCs than mam-RRV at all time points, with peak infection
at 12 hpi (Fig. 2A). However, the levels of type I IFN in the
supernatants were significantly lower from the mosquito virus-
infected cultures compared to the mammalian virus-infected
cultures at the 9-, 12-, and 20-h time points (Fig. 2B). Only at
20 hpi was IFN detectable by bioassay following mos-RRV
infection; however, this response was approximately 10% of
the IFN induction in mam-RRV-infected cultures (242 IU/ml
compared to 2,138 IU/ml in mam-RRV-infected cultures) in a
representative study. The low level of IFN in mos-RRV cul-
tures at 20 hpi may reflect secondary infection in the culture
where virus produced by the infected mDCs would have prop-
erties of mammalian-cell-derived virus.
Particle differences do not explain the differential type I IFN
induction by mam- and mos-RRV. Since alphavirus defective
interfering particles have been shown to induce type I IFN (11,
12) and inactivated RRV and SFV particles induce type I IFN
responses in mDCs (Fig. 1f) (15), particle-to-PFU ratios for
mam- and mos-RRV were calculated. If the mam-RRV prep-
arations contained a larger number of particles per PFU than
mos-RRV, excess particles might be responsible for the differ-
ence in type I IFN induction between the two RRV prepara-
tions. However, when the ratio of viral particles per PFU was
determined for mam- and mos-RRV stocks, mos-RRV had
6.6- to 11-fold more particles/PFU than the mammalian-cell-
derived virus stocks (Fig. 3). To confirm these results, two
additional assays were used to evaluate the ratio of particles or
genomes per PFU for both viruses.
Quantitative real-time PCR was used to measure the relative
numbers of RRV genomes between mam- and mos-RRV. This
assay indicated that there were two- to fourfold more genomes/
FIG. 2. mos-RRV infects more mDCs yet induces less type I IFN
than mam-RRV over time. A. Immature murine mDCs were infected
with either mos- or mam-RRV at a multiplicity of infection of 20, and
wells were harvested at the indicated times and assessed for GFP-
positive cells by flow cytometry. B. Supernatants from panel A were
collected, and type I IFN was measured by IFN bioassay. Solid lines
represent mam-RRV, and dotted lines represent mos-RRV. Each data
point represents the mean and standard error of the mean of three
samples. Data are representative of at least three independent exper-
iments.
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PFU of mam-RRV compared to mos-RRV (Fig. 3). Addition-
ally, semiquantitative Western blot assays were performed to
measure relative glycoprotein and capsid content of both mam-
and mos-RRV (Fig. 3C and D). This assay, where equivalent
PFU of each stock were analyzed by Western blotting with
polyclonal antiserum recognizing the viral E2 glycoprotein and
capsid, showed some variation where matched mam- and mos-
RRV virus preparations ranged from equivalent levels of gly-
coprotein and capsid signal to either virus stock having up to
two- to sixfold more glycoprotein- and capsid-specific signal
than the corresponding virus stock from the other cell type.
However, we saw no differences in the type I IFN induction
phenotype for mam- and mos-RRV virus stocks, regardless of
whether the virus stocks had equivalent capsid/glycoprotein
signal or if mos-RRV had more or less glycoprotein-specific
signal than the matched mam-RRV stock. This suggests that
higher particle/PFU ratios of mam-RRV do not explain the
difference in type I IFN induction. However, the higher ratio of
genomes/PFU of mam-RRV compared to mos-RRV detected
by the real-time PCR assay (Fig. 3B) could result in enhanced
IFN induction. Therefore, we performed dose-response exper-
iments to determine whether small differences in genome-to-
PFU ratios between the mammalian- and mosquito-derived
viruses could contribute to the differential IFN induction. My-
eloid DCs derived from wild-type 129Sv/Ev mice were infected
with mam-RRV or mos-RRV over a range of MOI (0.8 to
100.0 PFU/cell), and the percentage of infected cells and levels
of type I IFN were determined at 12 hpi. As shown in Figure
4A, mos-RRV infected a higher percentage of cells than mam-
RRV at all MOIs tested; however, mam-RRV infection in-
duced higher levels of type I IFN at MOIs from 4 to 100 (Fig.
4B). The fact that mam-RRV induced higher IFN levels than
mos-RRV over a 25-fold range of input virus, where mam-
RRV induced more type I IFN at an MOI of 4.0 than mos-
RRV at an MOI of 100.0, supports the idea that differences in
particle number between the virus stocks are not solely respon-
sible for the differences in IFN induction.
Differential type I IFN induction enhances mDC infection by
mosquito-cell-derived RRV. The observation that mos-RRV
infected a higher percentage of mDCs than mam-RRV but was
a poor inducer of type I IFN compared to mam-RRV raised
the question of whether enhanced DC infection by mos-RRV
was due to the viral effects on type I IFN induction. Therefore,
mDCs were generated from mice lacking a functional type I
IFN receptor (32) and infected with mosquito- or mammalian-
cell-derived RRV at the same range of MOIs utilized in wild-
FIG. 3. Comparison of particle-to-PFU ratios for mam-RRV and mos-RRV. A. The total counts per minute/PFU ratio for both mam- and
mos-RRV were determined by [35S]methonine labeling of virus particles followed by a plaque assay. The data are represented as the fold difference
in particle-to-PFU ratio between mos-RRV and mam-RRV. B. The relative number of genomes for both mos- and mam-RRV was determined
using a virus-specific real-time PCR assay. Data are presented as the fold difference in genome-to-PFU ratio between mos- and mam-RRV. C.
Equal PFU of mos- and mam-RRV contain similar amounts of glycoprotein, as shown by Western blotting of serial twofold dilutions of mam- and
mos-RRV probed with a polyclonal anti-RRV antibody. D. Fluorescent signal quantified for capsid bands from either mos- or mam-RRV
presented as in panel C.
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type mDCs as in the experiment shown in Fig. 4. In contrast to
the wild-type 129 mDCs, where mos-RRV showed enhanced
infection, the type I IFN receptor-deficient mDCs showed
equivalent levels of infection by viruses derived from either
mammalian or mosquito cells (Fig. 5A). This result strongly
suggests that the ability of mos-RRV to avoid or suppress the
induction of the type I IFN response in infected cultures en-
hances that virus’s ability to infect wild-type mDCs.
Another important question was whether the differences in
type I IFN induction between mos- and mam-RRV were due
to a block of the initial IFN induction or an inhibition of
amplification of the IFN response within the cultures. In most
cells, including mDCs, the type I IFN response is an amplifi-
cation loop, where a subset of early IFN genes (e.g., IFN- and
IFN-4) are induced early in the virus infection, and these
proteins then signal through the type I IFN receptor in an
autocrine or paracrine manner to induce much higher levels of
their own expression as well as the expression of late interferon
genes (reviewed in reference 3). The absence of signaling from
the receptor significantly reduces the levels of IFN induced
both at the protein and mRNA level. The quantitative RT-
PCR results, which showed significant differences in IFN-
mRNA induction between mos- and mam-RRV-infected cul-
tures at 2 hpi (Fig. 1D) strongly suggested that the differences in
type I IFN production between the mammalian and mosquito
virus-infected cultures were at the level of the initial IFN induc-
tion. However, to test this further, IFN levels were measured in
mDC cultures derived from the type I IFN receptor-deficient
mice, as these cells are able to induce early IFN gene expression
but the lack of type I IFN receptor signaling in these cells prevents
amplification of the response (32). As shown in Fig. 5B, mam-
RRV was able to induce type I IFN in the interferon receptor-
deficient mDCs, while mos-RRV failed to induce detectable type
I IFN responses as measured by bioassay. These results indicate
that the mosquito-cell- and mammalian-cell-derived viruses differ
in their ability to induce type I IFN, though an effect on the
amplification step cannot be ruled out.
A single passage of Mos-RRV through BHK-21 cells re-
stores the ability of the virus to induce type I IFN in mDC
cultures. It is possible that genetic differences between mam-
and mos-RRV explain the enhanced infection and decreased
IFN production on mDCs. To test the stability of the mos-
FIG. 4. mam-RRV induces more type I IFN than mos-RRV over a
broad range of viral doses. A. Infection percentages of immature
mDCs from 129 Sv/ev mice infected with either mam- or mos-RRV
ranging from 100 to 0.8 at 12 h postinfection. B. Type I IFN responses
measured from the same cultures as in panel A. Solid lines represent
mam-RRV, and dotted lines represent mos-RRV. Each point repre-
sents the mean and standard error of the mean of three samples.
Differences between mam- and mos-RRV were statistically significant
(P  0.05) for all input doses except 0.8, as determined by a two-tailed
unpaired Student’s t test.
FIG. 5. mam-RRV induces more type I IFN than mos-RRV in 129
 receptor-deficient mDCs. A. Infection percentages of immature
mDCs from type I IFN receptor-deficient mice infected with mam- or
mos-RRV at 12 h postinfection. B. IFN responses measured from the
same samples as in panel A. Solid lines represent mam-RRV, and
dotted lines represent mos-RRV. Each point represents the mean and
standard error of the mean of three samples. Data are representative
of at least three independent experiments.
242 SHABMAN ET AL. J. VIROL.
RRV phenotype, the mosquito-cell-derived virus, which was a
poor type I IFN inducer, was passaged once at an MOI of 1
through BHK-21 cells, and the resulting mam-RRV virions
were placed on mDCs (Fig. 6). A single passage of mos-RRV
in mammalian cells resulted in a reduction of infection effi-
ciency (Fig. 6A) on mDC cultures as well as an increase in type
I IFN induction (Fig. 6B). This suggests that the lack of IFN
induction by mos-RRV is likely not due to a coding change(s)
in the viral genome, as genetic variation would not be pre-
dicted to consistently occur after just a single passage. Further-
more, these results strongly suggest that evasion of type I IFN
induction by mos-RRV in the vertebrate host would only apply
to the first infected cells, since progeny virions would have the
properties of mammalian-cell-derived virus.
Differential type I interferon responses between mosquito-
and mammalian-cell-derived viruses occur with other alpha-
viruses. To evaluate whether type I IFN differences on primary
mDCs were specific to RRV or applied to other alphavi-
ruses, similar experiments were performed with VEE and
BFV. Previous studies have demonstrated that VEE infects
human dendritic cells in vitro (30) as well as murine mDCs
in vitro (T. P. Moran, M. Pressley, and R. E. Johnston,
unpublished data) and targets murine dendritic cells in vivo
(26). Consistent with previous data, VEE was able to infect
mDCs in vitro and, similar to RRV, mos-VEE infected more
mDCs at 12 hpi than mam-VEE at 12 hpi (Fig. 7A), yet
mos-VEE induced less type I IFN than mam-VEE (Fig. 7B).
Similar results were observed following infection of mDCs
with mosquito- and mammalian-cell-derived Barmah Forest
virus (strain 10E101SC) in mDCs at 12 hpi by IFN bioassay
(Fig. 7C). These results suggest that the differential type I
IFN induction by the mosquito- and mammalian-cell-de-
rived viruses is not specific to RRV and in fact may be a
general trait of alphaviruses.
Differential N-linked glycosylation contributes to the differ-
ences in type I IFN induction by mosquito- and mammalian
cell-derived alphaviruses. The 10E101SC strain of BFV ini-
tially used in these studies differs from most BFV strains in
that it contains N-linked glycans on its E2 glycoprotein (S.
Mahalingam, unpublished data). The IFN bioassay results
shown in Fig. 7C were confirmed using a semiquantitative
RT-PCR assay for IFN- transcripts (Fig. 8A) and we next
assessed whether classical strains of BFV, which do not have
N-linked glycans on the E2 glycoprotein (22), also exhibited
the same phenotype. When the BH2193 strain of BFV, which
lacks N-linked E2 glycans, was assessed for type I IFN induc-
tion, there were no significant differences in type I IFN re-
sponses between mam- and mos-BFV by semiquantitative RT-
PCR (Fig. 7E). While there are likely to be other differences
between the two virus strains, these results strongly suggest
that the N-linked glycans on the E2 glycoprotein contribute to
the differential type I IFN induction by the mosquito- and
mammalian-cell-derived viruses.
We therefore tested whether the presence of high-mannose
N-linked glycans on mos-RRV were contributing to the poor
IFN induction phenotype. RRV stocks were generated in pa-
rental CHO cells (Pro-5) or mutant CHO cells (Lec-1). Lec-1
CHO cells lack GlcNAc glycosyl transferase and glycans are
blocked at the Man5-GlcNAC2-Asn intermediate. Therefore,
viruses generated in Lec-1 cells have high mannose but no
complex glycans on the virion (similar to mos-RRV), while the
parental Pro-5 RRV contains complex glycans (similar to
mam-RRV) (40, 41). Like mos-RRV generated from C6/36
cells, Lec-1 RRV was sensitive to endo--N-acetylglucosamini-
dase H (endo H) digestion, which is indicative of high-man-
nose glycans on the virion, while virus grown in BHK and Pro-5
cells was endo H resistant (data not shown). Furthermore,
virus derived from Pro-5 cells (complex glycans) induced type
I IFN in infected mDC cultures, while IFN levels in cultures
infected with Lec-1-derived virus (high mannose) were below
the limit of detection (Fig. 8C). Taken together, these data
indicate that the presence of complex versus high-mannose
glycans on the mammalian- and mosquito-derived viruses con-
tributes to their differential ability to induce type I IFN re-
sponses in infected dendritic cells.
FIG. 6. A single passage of mosquito-cell-derived virus (mos-RRV)
through mammalian cells (generating mam-RRV) restores type I IFN
induction in mDCs. A. Myeloid DCs were infected with mam-RRV,
mos-RRV, or mos-RRV passaged a single time back through BHK-21
cells. Infection percentages were calculated for GFP-positive cells by
flow cytometry at 12 h postinfection. B. Supernatants from each of the
corresponding samples were evaluated by type I IFN bioassay. Data
are from a representative experiment and are presented as the mean
and standard error of the mean of three independent samples. mam-
RRV compared to mos-RRV and mos-RRV compared to mos-RRV
passaged through mammalian cells (mos-RRV 3 mam-RRV) were
statistically significant (P  0.05) as determined by one-way ANOVA
for the experiments in both panels A and B. mam-RRV compared to
mos-RRV3 mam-RRV was not statistically significant as determined
by one-way ANOVA for both panels A and B.
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DISCUSSION
The transition from the arthropod vector to the vertebrate
host is a critical step that is likely to play a major role in
determining whether arboviruses successfully establish infec-
tion and disseminate throughout the vertebrate host. There-
fore, mechanisms that would enable the newly delivered arbo-
virus to subvert the type I IFN response in mDCs may provide
an advantage to the virus as it establishes infection in the
vertebrate host. A number of factors, including virally encoded
interferon antagonists, (1, 4, 33, 44) and immunosuppressive
components of the arthropod saliva (23, 24, 37), are thought to
modulate the host antiviral response against arthropod-borne
viruses. However, the question of whether viruses delivered by
the mosquito vector differ from mammalian-cell-derived vi-
ruses with respect to their ability to induce type I interferon
responses has not previously been addressed.
In this report, we demonstrate that mammalian-cell-derived
alphaviruses are potent inducers of type I IFN in mDCs, while
mosquito-cell-derived viruses are poor inducers of type I IFN.
This suggests that the virus initially delivered by the mosquito
vector is able to suppress or avoid the induction of type I IFN
in the initially infected dendritic cell. It is possible that this
FIG. 7. Mosquito-cell-derived VEE virus and BFV induce less type I
IFN than mammalian-cell-derived viruses on mDCs. A. Myeloid DCs
were infected with mam- and mos-VEE at an MOI of 8.0, and infectivity
was calculated by flow cytometry based on GFP expression at 12 h postin-
fection. B. Supernatants from the same samples as in panel A were
analyzed by type I IFN bioassay. C. mos-BFV (strain 10E101SC) with E2
N-linked glycans induces less type I IFN than mam-BFV at 12 h postin-
fection by IFN bioassay. Data in panels A and B represent the mean and
standard error of the mean of three independent samples and are repre-
sentative of results from two independent experiments. Differences be-
tween mam- and mos-VEE were statistically significant (P  0.05) as
determined by one-way ANOVA (A and B).
FIG. 8. Glycosylation differences between mammalian- and mos-
quito-cell-derived virions of BFV and RRV contribute to differential
type I IFN induction in myeloid DCs. A. Analysis of IFN induction by
mam- or mos-BFV (strain 10E101SC), which has N-linked glycans on
the E2 glycoprotein. mos-10E101SC BFV induced less type I IFN than
mam-10E101SC BFV at 12 h postinfection as measured by RT-PCR
for IFN- transcripts. B. RT-PCR analysis for IFN- message in
mDCs following infection with BFV strain BH2193, which lacks gly-
cosylation sites on the E2 glycoprotein. Both mos- and mam-BH2193
BVF induced IFN- mRNA in infected mDCs. Each lane represents
an independent sample. C. Virus derived from wild-type Pro-5 CHO
cells (complex carbohydrates) induced more type I IFN in infected
mDC cultures than virus derived from mutant Lec-1 CHO cells (high-
mannose N-linked glycans) as measured by bioassay.
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intrinsic ability of the mosquito-cell-derived virus to avoid
the induction of a type I IFN response acts in concert with
immunosuppressive factors present in arthropod saliva
and/or virally encoded interferon antagonists to promote
the successful transition of the virus from the arthropod
vector to the vertebrate host.
Recent work with several mosquito-borne viruses, including
dengue virus and VEE, have demonstrated that dendritic cells
and/or Langerhans cells are an early target of viral replication
following delivery into the skin (6, 26, 35, 46). Furthermore,
the presence of high-mannose glycans on mosquito-derived
Sindbis and West Nile virions has been shown to enhance viral
infection of dendritic cells via interactions with the dendritic
cell-specific mannose binding lectins DC-SIGN (CD209) (6,
18). The findings presented in this paper indicate that mosquito-
derived viruses not only have an enhanced ability to infect
murine dendritic cells, compared to mammalian-cell-derived
viruses, but that these viruses also suppress or avoid the induc-
tion of type I IFN responses in infected dendritic cell cultures.
Furthermore, this effect on interferon induction is likely to
contribute to the enhanced infection efficiency of mDCs by the
mosquito-derived virus, as evidenced by the decrease in infec-
tion differences between mam- and mos-RRV in type I IFN
receptor-deficient DCs compared to wild-type DCs (Fig. 5B).
Myeloid DCs are capable of quickly responding to the in-
coming virus by mounting a very rapid antiviral response. This
response has been shown to be independent of MyD88 for
Semliki Forest virus, another alphavirus (15), and preliminary
experiments with RRV and VEE indicate type I IFN induction
in mDCs is MyD88 and Toll-like receptor 3 independent (R. S.
Shabman, T. Morrison, and M. Heise, unpublished results).
Furthermore, several studies have shown that mDCs rely on
the RIG-I/Mda5 pathway to sense incoming viruses and induce
type I IFN responses (16). Although a growing body of evi-
dence indicates that mDCs can rapidly respond to viral infec-
tions and that they play a central role in regulating the host
immune response to incoming pathogens, these cell types are
also an early target for arbovirus replication. Our results sug-
gest that the virus initially delivered by the mosquito vector
differs from the virus subsequently produced in mammalian
cells, and this difference may allow the mosquito-derived virus
to avoid induction of an antiviral response in the initially in-
fected DC.
One of the major differences between the mosquito- and
mammalian-cell-derived viruses is the exclusive presence of
mannose glycans (high mannose and paucimannose) on the
mosquito-derived viruses and complex/hybrid/high-mannose
glycans on the mammalian-cell-derived virus (25). A role for
N-linked glycans in mediating the differential type I IFN in-
duction by the mammalian- and mosquito-derived viruses is
supported by the finding that the 10E101SC strain of Barmah
Forest virus, which has N-linked glycans on its E2 glycoprotein,
exhibited the differential type I IFN induction, while the
BH2193 strain, which lacks N-linked glycans on its E2 glyco-
protein, showed no difference in type I IFN induction between
the mammalian- and mosquito-derived virus preparations (Fig.
8A and B). Furthermore, RRV generated in Pro-5 cells with
complex glycan additions induced more type I IFN on mDCs
than RRV generated in Lec-1 cells, which contain exclusively
mannose glycans (Fig. 8C). Therefore, additional studies are
needed to directly assess the role of N-linked glycans in this
phenotype, since it is possible that high-mannose glycans on
the mosquito-derived virus interact with C-type lectins on den-
dritic cells, resulting in an inhibition of type I IFN from the
mDC cultures. This is intriguing, since previous data indicate
that ligation of DC-SIGN, the mannose receptor, or other
C-type lectin receptors suppresses or modifies Toll-like receptor
signaling in human mDCs and pDCs (5, 9, 14, 20). Therefore,
additional studies on the role of high-mannose glycans on the
mosquito-cell-derived virus in blocking type I IFN induction by
the virus are required.
Experiments presented here were designed to explore sev-
eral potential mechanisms other than the presence of high-
mannose species on the mosquito-cell-derived viruses, includ-
ing nonviral factors, differences in the number of defective
interfering particles, which are known to be potent inducers of
type I IFN (11, 12), or genetic differences in the viruses derived
from the mammalian versus mosquito cells.
Several lines of evidence argue against nonviral factors being
responsible for the differing type I IFN induction between the
mosquito- and mammalian-cell-derived viruses. First, the re-
sults are highly reproducible between multiple virus prepara-
tions and with several different alphaviruses. Secondly, the type
I IFN induction by mam-RRV appears to be virus specific,
since the IFN inductive capacity separated with the ultracen-
trifuged virus pellet. Boiling, which would denature the virus,
but not lipopolysaccharide, which can also induce type I IFN
(13), abolished the ability of the virus preparation to induce
type I IFN.
The finding that multiple assays comparing mos- and mam-
RRV preparations vary in their particle-to-PFU ratio by only
2- to 11-fold, while the difference in type I IFN induction in
mDCs occurs over a 25-fold range of input virus, argues against
a role for defective interfering particles being responsible for
the type I IFN induction differences. A role for genetic differ-
ences between the mosquito- and mammalian-derived viruses
cannot be ruled out. Strong selection can rapidly select for
adaptive mutations in alphaviruses (19, 34); however, the fact
that a single pass through mosquito or mammalian cells repro-
ducibly results in a switch in the interferon induction pheno-
type argues against this possibility or suggests that an ex-
tremely strong selection event is occurring that selects for a
genetic change leading to poor type I IFN induction. Finally, it
is possible that in addition to differential glycosylation, differ-
ences in viral cholesterol content, or modifications to the viral
nucleic acid in a cell-type-specific manner could affect the
ability of the virus to induce type I IFN responses in mDCs but
not other cell types. Therefore, additional studies are needed
to address these possibilities.
The poor IFN induction by mosquito-cell-derived viruses
was observed for several different alphavirus family members.
These included RRV, VEE, and BFV, suggesting that poor
IFN induction by mosquito-derived virus may be a general trait
of alphaviruses. Whether this effect is specific to alphaviruses
or reflects a more general trait of arthropod-borne viruses is an
important question that remains to be determined. However,
these studies demonstrate that at least a subset of mosquito-
derived viruses are able to infect dendritic cells without initi-
ating a potent antiviral response. Though this effect is likely to
only occur during the initial round of replication, since the
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subsequent mammalian-cell-derived virus would be expected
to induce an IFN response (Fig. 6), this may be sufficient to
give the incoming virus an advantage that permits the estab-
lishment of infection. Therefore, further study of the mecha-
nisms underlying the ability of the mosquito-cell-derived al-
phaviruses to avoid or suppress type I IFN induction in mDCs
is likely to significantly enhance our understanding of how
mosquito-borne viruses initially establish infection and interact
with the host innate immune system.
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